日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study

法国按需使用血管性血友病替代疗法患者的医疗资源利用情况及相关成本的真实世界证据:FORvWARD 研究

Polack, Benoit; Nerich, Virginie; Micallef, Claire Marant; Trossaërt, Marc; Biron-Andreani, Christine; Bornier, Nadège; Chatelanaz, Catherine; Favre-Besse, Franck; Beoletto, Julien; Née, Mélanie; Belhassen, Manon; Lefèvre, Cinira; Pouvourville, Gérard de

Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study

在常规临床实践中,使用因子XI替代疗法治疗遗传性因子XI缺乏症:HEMOLEVEN前瞻性3年上市后研究的结果

Bauduer, F; de Raucourt, E; Boyer-Neumann, C; Trossaert, M; Beurrier, P; Faradji, A; Peynet, J; Borg, J-Y; Chamouni, P; Chatelanaz, C; Henriet, C; Bridey, F; Goudemand, J